From Party to Prescription: How Psychedelics Are Changing Traditional Psychiatry

From Party to Prescription: How Psychedelics Are Changing Traditional Psychiatry

An array of drugs often used for recreation are now being studied and used in psychiatry. Stephen Dubner of Freakonomics Radio and three Mount Sinai neuroscientists discuss how ketamine, cannabis, and ecstasy are showing promise as potential treatments for treatment-resistant depression, opioid addiction, and post-traumatic stress disorder. They discuss the science and public policy regarding these substances, as well as the potential benfits and possible downsides. This episode was recorded live, via Zoom, in collaboration with The Greene Space at WNYC.


Published

September 30, 2020

Created by

Physician's Channel - Mount Sinai New York

Featured Faculty

Yasmin Hurd, PhD

Yasmin Hurd, PhD

Professor, Neuroscience, Psychiatry, and Pharmacological Sciences
Icahn School of Medicine at Mount Sinai
Director, Addiction Institute at Mount Sinai

View full profile

James Murrough, MD

James Murrough, MD

Director, Depression and Anxiety Center
The Mount Sinai Hospital
Associate Professor, Psychiatry, and Neuroscience
Icahn School of Medicine at Mount Sinai

View full profile

Rachel Yehuda, PhD

Rachel Yehuda, PhD

Director, Traumatic Stress Studies Division
Vice Chair, Veterans Affairs
Professor, Psychiatry, and Neuroscience
Icahn School of Medicine at Mount Sinai

View full profile